


GJB2

Anti-GJB2 Products
-
- Derivation: Phage display library
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, WB, IF, Inhib
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB, ELISA, IHC
-
- Derivation: Phage display library
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB, IF, Inhib
-
- Derivation: Phage display library
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB, IF, Inhib
- Human Anti-GJB2 (clone abEC1.1) scFv-Fc Chimera (VS-0325-FY123)
-
- Species Reactivity: Human
- Type: Human IgG1, scFv-Fc
- Application: ELISA, WB, IF, Inhib
-
- Species Reactivity: Human
- Target: GJB2
- Host Animal: Human
- Application: ELISA, FC, Inhib, Cell-uptake
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs offers a comprehensive selection of validated anti-GJB2 recombinant antibodies. These high-quality reagents are rigorously validated to ensure optimal performance in a variety of applications, including Western blotting, immunohistochemistry, immunofluorescence, and ELISA. By leveraging our expertise in recombinant antibody technology, we provide researchers with reliable tools to advance their studies in cell biology, disease modeling, and drug discovery.
GJB2: An Important Target for Cancer Therapy
The GJB2 gene encodes connexin 26, a protein involved in cell-to-cell communication. Beyond its role in normal cellular function, connexin 26 has been implicated in cancer development and progression. Abnormal expression of connexin 26 has been linked to various cancers, including colorectal, breast, and bladder cancer. Overexpression of connexin 26 can increase cancer cell motility, invasion, and stem cell-like features. Given its potential role in cancer, targeting connexin 26 presents a promising therapeutic strategy for cancer treatment.
Alternative Names
CX26; CXB2_HUMAN; DFNA3; DFNB1; gap junction protein, beta 2, 26kDa; NSRD1; Gap Junction Beta-2 Protein; Connexin 26; Mutant Gap Junction Beta 2 Protein; BAPS 3; Cx26 4; HID 3; KID 3; PPK.
Background
This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness.
Disease related genes, Human disease related genes, Potential drug targets, Transporters
Membrane
Cell type enhanced (Basal respiratory cells, Squamous epithelial cells, Basal keratinocytes, Basal squamous epithelial cells, Ionocytes)
Not detected in immune cells
Group enriched (CAPAN-2, hTCEpi, OE19, RT4)
A hemichannel or connexon is composed of a hexamer of connexins. A functional gap junction is formed by the apposition of two hemichannels (PubMed:17551008, PubMed:19340074, PubMed:21094651, PubMed:26753910). Interacts with CNST (PubMed:19864490). Forms heteromeric channels with GJB4 (By similarity).
Anti-GJB2 rAb Products
Creative Biolabs offers a diverse spectrum of recombinant anti-GJB2 antibodies that have been rigorously developed to provide maximum specificity and affinity. These antibodies are appropriate for a variety of research applications, including basic research and therapeutic development, and come in a variety of forms. Our innovative platform enables us to provide high-quality tools that improve our understanding of cellular and molecular biology, with a particular emphasis on immunology and cancer research.
Table 1. Featured anti-GJB2 recombinant antibody products at Creative Biolabs.
Cat. No. | Product Name | Target Species | Host Species | Applications |
PABC-396 | Human Anti-GJB2 Recombinant Antibody (clone abEC1.1) | Human | Human | ELISA, WB, IF, Inhib |
MOB-2985z | Mouse Anti-GJB2 Recombinant Antibody (clone 24H11) | Human | Mouse IgG1, κ | WB, ELISA, IHC |
PFBC-396 | Human Anti-GJB2 Recombinant Antibody (clone abEC1.1); Fab Fragment | Human | Human Fab | ELISA, WB, IF, Inhib |
PSBC-396 | Human Anti-GJB2 Recombinant Antibody (clone abEC1.1); scFv Fragment | Human | Human scFv | ELISA, WB, IF, Inhib |
Creative Quality Control
Creative Biolabs offers a comprehensive range of validated anti-GJB2 recombinant antibodies. These antibodies are engineered to exhibit exceptional specificity, stability, and efficacy. Our stringent quality control measures guarantee that every antibody fulfills the highest industry requirements. These high-quality antibodies are invaluable tools for researchers investigating the role of connexin 26 in cancer research.
Fig.1 SDS-PAGE analysis of anti-GITR antibody
(Cat# PABC-396, Creative Biolabs).
Customer Reviews

Human Anti-GJB2 Recombinant Antibody (clone abEC1.1) (PABC-396)

Human Anti-GJB2 Recombinant Antibody (clone abEC1.1); Fab Fragment (PFBC-396)

Mouse Anti-GJB2 Recombinant Antibody (clone 24H11) (MOB-2985z)
rAb Production
Creative Biolabs employs innovative genetic engineering techniques to produce excellent in quality anti-GJB2 antibodies, guaranteeing a consistent supply for a wide range of research applications.
Featured Anti-GJB2 Recombinant Antibody Production Platforms
Fig.2 Milligram-scale anti-GJB2 recombinant antibody production.
Fig.3 Gram-scale anti-GJB2 recombinant antibody production.
rAb Modalities
Creative Biolabs offers an extensive range of premium anti-GJB2 recombinant antibodies designed to cater to research needs worldwide.
Fig.4 Full-length anti-GJB2 recombinant antibody production and modalities.
GJB2-Targeted Drug Information
Table 2. Public drug targeting GJB2.
Highest Phase | Mechanism of Action | Product Category | Condition | Organization |
Decibel Therapeutics (Originator) Regeneron |
Preclinical |
Adeno-Associated Viral (AAV) Vectors Gene Therapy |
Hearing loss | |
Institut Pasteur (Originator) Sensorion |
Preclinical | Gene Therapy |
Ear genetic disorders Hearing loss Presbycusis |
|
MD Anderson Cancer Center (Originator) | Preclinical |
Adenoviral Vectors Gene Therapy |
Cancer | |
Decibel Therapeutics (Originator) Regeneron (Originator) |
Biological Testing |
Adeno-Associated Viral (AAV) Vectors Gene Therapy Regenerative Medicines |
Hearing loss | |
Korro Bio (Originator) | Biological Testing |
Engineered Nucleases Single Guide RNA (sgRNA) Single-stranded oligoribonucleotide (RNA) |
Hearing loss | |
Akouos (Originator) | Biological Testing |
Adeno-Associated Viral (AAV) Vectors Gene Therapy |
Hearing loss | |
Beacon Therapeutics (Originator) | Biological Testing |
Adeno-Associated Viral (AAV) Vectors Gene Therapy |
Nonsyndromic sensorineural deafness | |
ShanghaiTech University (Originator) | Biological Testing |
Cancer Immunotherapy Diabodies Fc Fusion Proteins Polypeptides, from 41 AA |
Clouston hidrotic ectodermal dysplasia Keratitis-ichthyosis-deafness syndrome X-linked Charcot-Marie-Tooth disease |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Feel free to reach out to us anytime for more information and inquiries about our anti-GJB2 recombinant antibody products.